Rhu-erythropoietin treatment of pre-ESRD patients slows the rate of progression of renal decline
Tapolyai, M.; Schede Don, K.; Gupta, B.
Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 91A
1999
ISSN/ISBN: 1046-6673 Document Number: 235088
Document emailed within 1 workday
Related Documents
Steinman, T. 2001: Is the decline in the growth rate in the ESRD population a true representation of the future Nephrology News and Issues 15(12): 30Lim, V.S. 1990: Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency? Seminars in Nephrology 10(2 Suppl. 1): 26-27
Balter, M. 1998: Chemokine mutation slows progression Science 279(5349): 327
Hu, J.P.; Cheng, X.; Xu, X.F.; Yu, G.J.; Luo, F.; Zhang, G.S.; Yang, N.; Shen, P.; Yan, X.Y. 2016: Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia Journal of Biological Regulators and Homeostatic Agents 30(2): 535-540
DiPaolo, V. 1978: Rate of contract increases slows Modern Healthcare 8(8): 18-19
Zelichowski, G.; Lubas, A.; Sienkiewicz, M.; Janusz, E.; Wańkowicz, Z. 2008: Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(142): 312-315
Yamazaki, C.; Watanabe, Y.; Sakamoto, N. 1993: Pharmacokinetic study of recombinant human erythropoietin treatment in pre-dialysis end stage renal disease patients Nihon Jinzo Gakkai Shi 35(11): 1233-1242
Alford, P.J. 1986: Turnover rate slows with creative training program Provider 12(4): 43-44
Wiecek, A.; Kokot, F.; Spiechowicz, U.; Cieplok, J.; Czerwieńska, B.; Strzelczyk, P.; Dyjas, R. 1996: Requirement for blood in hemodialyzed patients with chronic renal failure in the period before and after introduction to erythropoietin (r-HuEPO) treatment Przeglad Lekarski 53(12): 866-869
Lewy, J.E. 2001: Treatment of children in the U.S. with end-stage renal disease (ESRD) Medicinski Arhiv 55(4): 201-202
Ksiazek, A.; Baranowska-Daca, E. 1993: Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S550-S552
Dimitrakov, D.; Kumchev, E.; Tllkian, E. 1994: Study of the effect of recombinant erythropoietin on renal anaemia in predialysis patients with chronic renal failure Folia Medica 36(3): 31-36
Kulzer, P.; Schaefer, R.M.; Krahn, R.; Schaefer, L.; Heidland, A. 1994: Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group International Journal of Artificial Organs 17(4): 195-202
Apperloo, A.J.; de Zeeuw, D.; de Jong, P.E. 1994: Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease Kidney International. Suppl 45: S174-S178
Lefton, C.K. 1993: ACE inhibitor slows onset of renal disease in diabetics by 50% Nephrology News and Issues 7(12): 8; 11
Satirapoj, B.; Supasyndh, O.; Choovichian, P. 2014: A comparative study of efficacy and safety of the lyophilized powder alpha-erythropoietin and the liquid form alpha-erythropoietin for hemoglobin maintenance in patients with hemodialysis treatment Journal of the Medical Association of Thailand 97(9): 899-906
Cole, B.E. 1989: Pediatric ESRD patients & their special treatment challenges Nephrology News and Issues 3(8): 30-32
Afthentopoulos, I.E.; Oreopoulos, D.G. 1997: Is CAPD an effective treatment for ESRD patients with a weight over 80 kg? Clinical Nephrology 47(6): 389-393
Blumberg, A.; Zehnder, C. 1988: Treatment of renal anemia using synthetic human erythropoietin Therapeutische Umschau. Revue Therapeutique 45(12): 895-899
Dyjas, R.; Wiecek, A.; Kokot, F. 1996: Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO Przeglad Lekarski 53(6): 486-490